PubAg

Main content area

MiR-451a attenuates free fatty acids–mediated hepatocyte steatosis by targeting the thyroid hormone responsive spot 14 gene

Author:
Zeng, Ni, Huang, Rong, Li, Nan, Jiang, Hongmei, Li, Ruobi, Wang, Fei, Chen, Wen, Xia, Min, Wang, Qing
Source:
Molecular and cellular endocrinology 2018 v.474 pp. 260-271
ISSN:
0303-7207
Subject:
3' untranslated regions, crosslinking, databases, environmental factors, fatty liver, free fatty acids, gene overexpression, genes, humans, liver, luciferase, mice, microRNA, models, oleic acid, palmitates, precipitin tests, protein synthesis, therapeutics, thyroid hormones, triacylglycerols
Abstract:
The thyroid hormone responsive spot 14 (THRSP) gene is a de novo lipogenesis-related gene that plays a significant role in the initiation and development of nonalcoholic fatty liver disease (NAFLD). Several previous studies had shown that endogenous and environmental factors could regulate the expression of THRSP. The role of microRNAs (miRNAs), however, in controlling THRSP expression has not been investigated. In this study, we first constructed the hepatic steatosis cell model by using a mixture of free fatty acids (FFAs; oleate/palmitate, 2:1 ratio) to treat and demonstrate the promotive role of THRSP in lipid accumulation in hepatic cells. By analyzing the photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) database and performing a luciferase reporter assay, we confirmed that microRNA-451a specifically binds to mouse and human THRSP 3′UTR and inhibits its activity. Overexpression of miR-451a efficiently reduced THRSP mRNA and protein expression as well as triglyceride (TG) accumulation in cultured hepatic cells (AML12 and HepG2). Moreover, overexpression of miR-451a significantly decreases TG accumulation in the livers of mice injected with an miR-451a agomir. All these results demonstrated that miR-451a might participate in the FFA-induced hepatic steatosis by regulating the expression of the THRSP gene which represents a new potential target for NAFLD therapy.
Agid:
6106730